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1    INTRODUCTION
According to the Advisory Committee on 
Immunization Practices (ACIP) in the United States, 
inactivated influenza vaccination is 30-70% effective in 
preventing hospitalization for pneumonia and influenza 
among elderly persons not living in nursing homes 
or chronic-care facilities. Annual vaccinations are 
recommended for those groups, as well as the residents 
of nursing homes and for those groups with high-risk 
medical conditions1). The Japanese Ministry of Health, 
Labour and Welfare recommended a vaccination 
including the assistance though public funds, for a senior 
citizens older than 65 years old from 2001, because 
they recognized the elderly to be a high-risk group for 
influenza.
Most observational studies about the effectiveness of 
influenza vaccines in community-dwelling elderly have 
been investigated by linkage to large scale databases2-10). 
Because existing administrative databases cannot be used 
to evaluate the effectiveness of influenza vaccination in 
Japan, another approach to evaluate the effectiveness of 
an influenza vaccination is needed11). All subjects should 
be followed equally thorough the influenza season to 
examine the effects of the influenza vaccination for 
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influenza-like illness (ILI) and high fever, as such studies 
have so far mostly been limited to elderly residents in 
nursing homes12,13). In general, little is known about the 
vaccine effectiveness for ILI in community-dwelling 
elderly14). In the previous cohort study in Saga, Japan15), 
influenza vaccination decreased ILI significantly 
(OR=0.38; 95%CI=(0.17,0.85)) after adjusting for 
confounders. This present study was a population-based 
cohort study, conducted during the 06/07 season to 
examine the effectiveness of an influenza vaccine among 
community-dwelling elderly in Sapporo, Japan.
2    SUBJECTS AND METHODS
We selected 1,000 elderly citizens ranging from 
65 to 74 years old randomly from a population registry 
of Sapporo City in September 2006. We sent them a 
letter with an explanation of the study and requesting for 
their participation. The eligibility criteria to participate 
in study were as follows; not being hospitalized, not 
being institutionalized, and having access to contact by 
telephone at least once a month. As a baseline survey in 
October or November 2006, we asked them to answer 
the self-administered questionnaire about baseline 
characteristics that might act as potential confounders 
including: a history of influenza vaccinations (this 
season(06/07), pre-season(05/06), and the season before 
last(04/05)), a diagnosis of influenza (this season(06/07), 
pre-season(05/06), and the season before last(04/05)), 
health condition by self report, health status (underlying 
disease etc), history of ILI, vaccination, smoking habits, 
exercise habits, going out to crowded areas, history of 
hospitalizations for pneumonia, day care or day service 
or short stay use, hand washing and gargling habits, and 
family constitution. Among the 1,000 elderly citizens, 
542 (54.2%) subjects responded with a written informed 
consent. We excluded one person because he passed away 
before the follow-up survey. Thus, we followed-up and 
analyzed 541 subjects.
The survey period was defined as from 1 November 
2006 to 31 March 2007. We performed a follow-up 
survey by telephone in December 2006, and in January, 
February, March, and April 2007 (five times in total). 
Every month, we interviewed the elderly regarding 
ILI, acute febrile illnesses, hospitalizations, and death 
during the previous month by telephone. When an 
event occurred, we asked the elderly when the event 
did happen. ILI was defined that community-dwelling 
elderly have received a diagnosis at a hospital during the 
epidemic period in this study.
This study was approved by the Ethical Boards of 
Sapporo Medical University.
3    ANALYSIS
Statistical analyses were performed using the 
Statistical Package for Social Science (SPSS). The Chi-
square test and Mann-Whitney U-test were used to 
compare vaccinated group and non-vaccinated group. 
Cox’s hazard model was conducted to control for any 
confounding factors. The HR and their 95%CI were 
calculated for each factor based on the Cox’s hazard 
model coefficient and standard error. For each of the 
estimations, the HR was adjusted for gender, age, 
and underlying disease (one or more of the following 
criteria; high blood pressure, a cardiovascular disease, a 
respiratory system disease, diabetes, a cerebrovascular 
disease). A level of 0.05 was used as the critical level of 
significance.
4    RESULTS
A total of 541 community-dwelling elderly were 
followed during the 06/07 influenza season. Participants 
included 306 (56.6%) males with a mean age (± standard 
deviation; SD) of 69.5 ±2.9 years. The rate of vaccination 
was 56.7%. Table 1 shows a comparison of the baseline 
variables between the vaccinated group and the non-
vaccinated group. The vaccinated group was more likely 
to be female (p=0.01), older (p<0.01), to have underlying 
disease (p<0.01), to have never been a smoker (p=0.01), 
to have family medicine (p<0.01), and to gargle after 
returning home (p<0.01) than the non- vaccinated group.
Table 2 shows the ILI affection, and the vaccination 
situation in 2005/2006 (05/06) seasons. The vaccinated 
group in the 05/06 season was less likely to have an ILI in 
the 05/06 season (p<0.01), and more likely to vaccinate in 
the 06/07 season (p<0.01) than the non-vaccinated group 
in 05/06.
Table 3 illustrates the ILI affection and the 
vaccination situation in the 04/05 seasons. The vaccinated 
group in the 04/05 season was less likely to have an ILI in 
the 04/05 season (p=0.04), and more likely to vaccinate in 
the 06/07 season (p<0.01) than their counterparts.
The effect of the vaccine for each event is shown 
in Table 4. When the patients vaccinated, the risk of 
fever higher than or equal to 37.5˚C for the latter was 
reduced compared with their counterparts (crude: 
HR=0.47, 95%CI=(0.23, 0.97); adjusted: HR=0.42, 
95%CI=(0.20, 0.90)). We compared the groups with and 
without underlying diseases, and the factor of having an 
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underlying disease was not significant, although we did 
not show the data in the table.
Table 5 demonstrates the baseline characteristic in 
fevers higher than or equal to 37.5˚C. The group that had 
a fever higher than or equal to 37.5˚C were more likely to 
live together with a daughter (p=0.01), or kindergarten, 
nursery, or primary schoolchild (p=0.04) than the group 
that didn’t have a fever higher than or equal to 37.5˚C. 
Also, the group that had a fever higher than or equal to 
37.5˚C  were less likely to vaccinate in 05/06 (p=0.03) 
than their counterparts.
Table 2  Influenza-like illness (ILI) affection in the 05/06 seasons, and the vaccination situation in the 06/07 seasons; comparing the 
vaccinated group and non-vaccinated group in the 05/06 season
ILI in the 05/06 season
Vaccination in the 06/07season
The vaccinated group
in the 05/06 season
(n=282)
3 (1.1%)
263 (93.3%)
The non-vaccinated group 
in the 05/06 season
(n=259)
13 (5.0%)
44 (17.0%)
p-value$
<0.01
<0.01
number (%)
p-value$: Fisher’s exact test
Table 1 Baseline characteristic
Gender (Male)
Age (years old)
Having underlying disease (yes)*
Health condition (good, normal)
Smoking habits (yes)
Regular exercise (More than once a week)
Having family medicine (yes)
Going out to crowd areas (more than once a week)
Number of family members living together
Living together with a kindergarten, nursery, or primary schoolchild (yes)
Washes hands after returning home (yes)
Gargles after returning home (yes)
Using a day-care or day-service (More than once a week)
Using a short stay service (yes)
The vaccinated group
(n=307)
159 (51.8%)
70.0±2.8
189 (61.6%)
281 (91.5%)
39 (12.7%)
195 (63.5%)
259 (84.4%)
253 (82.4%)
2.7±1.4
23 (7.5%)
279 (90.9%)
256 (83.4%)
7 (2.3%)
1 (0.3%)
The non-vaccinated group
(n=234)
147 (62.8%)
68.8±2.9
107 (45.7%)
218 (93.2%)
50 (21.4%)
146 (62.4%)
154 (65.8%)
186 (79.5%)
2.6±1.1
11 (4.7%)
209 (89.3%)
169 (72.2%)
3 (1.3%)
2 (0.9%)
p-value$
0.01
<0.01
<0.01
0.52
0.01
0.79
<0.01
0.44
0.31
0.21
0.57
<0.01
0.53
0.58
number (%), means ± SD
underlying disease *: one or more of the following criteria: high blood pressure, a cardiovascular disease, a respiratory system disease, diabetes, a 
cerebrovascular disease
p-value$: Fisher’s exact test, Mann-Whitney’s U test.
Table 3  Influenza-like illness (ILI) affection in the 04/05 seasons, and the vaccination situation in the 06/07 seasons; compared 
vaccinated group and non-vaccinated group in the 04/05 season
ILI in the 04/05 season
Vaccinated in the 06/07season
The vaccinated group
in the 04/05 season
(n=231)
4 (1.7%)
208 (90.0%)
The non-vaccinated group
in the 04/05 season
(n=310)
16 (5.2%)
99 (31.9%)
p-value$
0.04
<0.01
number (%)
p-value$: Fisher’s exact test
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5    DISCUSSION
In the baseline characteristics, the vaccinated 
group was more likely to never have been a smoker, 
and gargle after returning home. There is possibility 
that the vaccinated group had a healthier consciousness 
than their counterparts, and there may have also been 
selection bias. The vaccinated group may have taken the 
recommendation of the vaccination more than the non-
vaccinated group, because the vaccinated group was more 
likely to have an underling disease and family medicine.
In the present study, the vaccinated group in the 
05/06 season was less likely to have an ILI in the 05/06 
season (the vaccinated vs. the non-vaccinated: 1.1% 
vs. 5.0%) and the vaccinated group in the 04/05 season 
was less likely to have an ILI in the 04/05 season (the 
Table 4  Effect of the vaccine for each event
Fever (≧37.0˚C)
          (≧37.5˚C)
          (≧38.0˚C)
ILI
Pneumonia
Hospitalization for influenza
The vaccinated group
(n=307)
27 (8.8%)
12 (3.9%)
10 (3.3%)
4 (1.3%)
2 (0.7%)
2 (0.7%)
The non-vaccinated group 
(n=234)
27 (11.5%)
19 (8.1%)
14 (6.0%)
4 (1.7%)
0 (0%)
0 (0%)
Hazard ratio**
(95%CI#)
0.74 (0.42, 1.29)
0.42 (0.20, 0.90)
0.48 (0.21, 1.12)
1.25 (0.29, 5.37)
- †
- †
number (%)
p-value$: Fisher’s exact test
CI#: confidence interval
The vaccinated group vs. the non-vaccinated group
Hazard ratio*: crude
Hazard ratio**: adjusted for sex, age, and underlying disease (one or more of the following criteria; high blood pressure, a cardiovascular diease, a 
respiratory system disease, diabetes, a cerebrovascular disease).
† : Could not be calculated.
Hazard ratio*
(95%CI#)
0.75 (0.44, 1.28)
0.47 (0.23, 0.97)
0.54 (0.24, 1.21)
0.75 (0.19, 3.01)
- †
- †
Table 5 Baseline characteristic in fever higher than or equal to 37.5˚C
Gender (Male)
Age (years old)
Having underlying disease* (yes)
Health condition (good, normal)
Smoking habits (yes)
Regular exercise (More than once a week)
Going out to crowded areas (more than once a week)
Number of family members living together
Living together with a daughter (including the justice) (yes)
Living together with a kindergarten, nursery, or primary schoolchild (yes)
Washes hands after returning home (yes)
Gargles after returning home (yes)
Using a day-care or day-service (More than once a week)
Using a short stay service (yes)
Vaccinated in the 05/06 (yes)
Vaccinated in the 04/05 (yes)
More higher than or equal to 37.5˚C p-value$
0.36
0.58
0.85
0.29
0.45
0.34
1.00
0.14
0.01
0.04
0.76
0.27
- **
- **
0.03
0.27
number (%), means ± SD
underlying disease *: one or more of the following criteria: high blood pressure, a cardiovascular disease, a respiratory system disease, diabetes, a 
cerebrovascular disease
p-value$: Fisher’s exact test, Mann-Whitney’s U test.
**: Could not be calculated.
15 (48.4%)
69.2±3.1
18 (58.1%)
27 (87.1%)
3 (9.7%)
17 (54.8%)
25 (80.6%)
3.1±1.9
13 (41.9%)
5 (16.1%)
29 (93.5%)
22 (71.0%)
0 (0%)
0 (0%)
10 (32.3%)
10 (32.3%)
Not having
(n=510)
291 (57.1%)
69.5±2.9
278 (54.5%)
472 (92.5%)
86 (16.9%)
324 (63.5%)
414 (81.2%)
2.6±1.2
109 (21.4%)
29 (5.7%)
459 (90.0%)
403 (79.0%)
10 (2.0%)
3 (0.6%)
272 (53.3%)
221 (43.3%)
Not having
(n=510)
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vaccinated vs. the non-vaccinated: 1.7% vs. 5.2%) than 
their counterparts. Hara et al16) reported vaccinated 
group were less likely to have ILI than non-vaccinated 
group. The result of the present study supported the 
result of the study16), though year in an influenza season, 
the type of endemic influenza viruses, and area in 
Japan were different. However, there is a possibility 
of misclassification11) or selection bias, because the 
vaccinated group may be likely to attend a hospital 
after they become sick. This study of effectiveness of 
an influenza vaccine in persons aged 65 years or over 
living in a community was limited17-19), especially in the 
effectiveness for ILI14, 20).
The vaccinated group in the 05/06 season was more 
likely to vaccinate in the 06/07 season than the non-
vaccinated group in the 05/06 (the vaccinated vs. the non-
vaccinated: 93.3% vs. 17.0%), and the vaccinated group 
in the 04/05 season was more likely to vaccinate in the 
06/07 season (the vaccinated vs. the non-vaccinated: 
90.0% vs. 31.9%) than their counterparts. If the 
community-dwelling elderly were vaccinated once, the 
elderly may be vaccinated again the next year. Therefore, 
it would be important for the Japanese Government to 
intervene to find ways to vaccinate for the elderly.
In this present cohort study among community-
dwelling elderly, influenza vaccination reduced the risk of 
a fever higher than or equal to 37.5˚C during the epidemic 
period. The result of the present study supported the 
result of the previous cohort study in Saga15). Critical 
point of high fever of this study (37.5˚C) was different 
from that of the previous study in Saga (38.5˚C)16). 
Because there are no other reports, to our knowledge, 
regarding effectiveness of influenza vaccine reducing 
risk of acute febrile illness, future study is necessary 
to identify the critical point of high fever for vaccine 
effectiveness. In a follow-up survey over the telephone, 
it was difficult to perform an influenza judgment in the 
present study because the survey asked a self-report, 
however it is correct for judging the fever. A high fever 
from influenza is an important health hazard in elderly in 
a community.
Comparison between a high-risk condition group 
and a low-risk condition group are important in a general 
influenza study21), and it was not significant in the present 
study. Although we compared risk of having ILI between 
a high-risk group and a low-risk group, it was not 
significantly different. No difference between them might 
occur from small sample size, relatively low response 
rate (54%), or low prevalence of pneumonia during this 
influenza seasons in Japan compared with a report in 
Europe22) . Such variables do not capture the important 
difference in health status between vaccinated and 
unvaccinated individuals, and the adjustment for these 
variables alone does not remove the confounding factors. 
In our future study, we will control for confounding with 
detailed medical record information.
In the present study, the group that had a fever 
higher than or equal to 37.5˚C was more likely to live 
together a daughter (p=0.01), or a kindergarten or nursery 
or a primary schoolchild (p=0.04) than the group that 
didn’t have a fever higher than or equal to 37.5˚C. There 
is possibility that a child brought the influenza virus into 
the house. ACIP1) has recommended that health-care 
workers take vaccination against seasonal influenza. It is 
thought that prevention in the whole family is important.
Certain limitations in the present study should 
be disclosed. First, the present study may have had a 
selection bias because the response rate was 54.2%. 
Second, the number of subjects was insufficient. Third, 
there was the possibility of misclassifications in the 
present study because the judgment of influenza was 
taken via a self-report, although we confined it to 
physician’s diagnosed ILI.
In conclusion, a population based cohort study was 
conducted during the 06/07 influenza season to examine 
the effectiveness of an influenza vaccine among 541 
community-dwelling elderly, ranging from 65 to 74 
years. After adjusting for confounders, the vaccination 
decreased acute fevers higher than or equal to 37.5˚C (HR 
=0.42, 95% CI=(0.20, 0.90)) during the epidemic period. 
Therefore influenza vaccinations may be decreased acute 
fevers during influenza epidemic periods in community-
dwelling elderly.
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2006-07 シーズンでの地域居住高齢者における
急性発熱疾患に対するインフルエンザワクチンの効果：
日本におけるコホート研究
大浦麻絵 1），大西浩史 1），原めぐみ 2），坂内文男 1），
伏木康弘 1），森　　満 1）
1）札幌医科大学医学部公衆衛生学
2）佐賀大学医学部社会医学
　背景：毎年のワクチン接種は，療養所などの入所者と
同様に，医学的高リスク集団に対し推奨されている．し
かしながら，地域居住高齢者におけるインフルエンザワ
クチン効果についてはほとんど分かっていない．
　方法：地域居住高齢者におけるインフルエンザワクチ
ン効果を調べることを目的とし，2006-2007 年（06/07）
のインフルエンザ流行期にコホート研究を行った．2006
年 9月に札幌市住民基本台帳から 65～ 74 才の地域居住
高齢者 1,000 人を無作為に選出した．ベースライン調査
は 2006 年 10 月，11 月に行われ，542 人（54.2％）が研
究参加に同意をした．追跡開始前に 1人死亡したため除
外し，541 人を解析対象者とした．2006 年 12 月から
2007 年 4月まで毎月（計 5回）電話による追跡調査を行
い，発熱，入院などの発生について尋ねた．カイ二乗検定，
Mann-Whitney の U検定でワクチン接種群と非接種群の
比較を行い，Coxの比例ハザードモデルを用い交絡要因
を調節したHazard Ratio（HR）を算出した．
　結果：補正後，ワクチン接種群は非接種群に比
べて 2006年 12月から 2007年 4月までの間の 37.5
度以上の発熱（HR＝ 0.42，95％信頼区間＝（0.29，
5.37））においてリスクが低下した．しかしながら，
インフルエンザ様疾患とは関係が無かった（HR＝
1.25，95％ CI＝（0.29，5.37））．
　まとめ：インフルエンザワクチン接種は，地域居住高
齢者に対しインフルエンザ流行期の発熱を減少させるこ
とが示唆された．
